Related Experiment Video
Updated: Jul 3, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Pravastatin: an evidence-based statin?
Antonio Iglesias del Sol1, Prabath W B Nanayakkara
1VU University Medical Center, Department of Internal Medicine, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
Pravastatin, a widely studied statin, effectively lowers cardiovascular risk by reducing cholesterol by 25-34%. It is safe for various populations and may be a cost-effective option globally.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Statins significantly reduce cardiovascular morbidity and mortality.
- Pravastatin is a well-established statin used in primary and secondary prevention.
- 40 mg daily pravastatin lowers total cholesterol by 25-34%, reducing cardiovascular death risk by 24%.
Purpose of the Study:
- To evaluate the efficacy and safety of pravastatin in cholesterol management.
- To determine pravastatin's role in achieving LDL cholesterol goals according to ATPIII guidelines.
- To assess the potential cost-effectiveness of pravastatin, particularly in developing countries.
Main Methods:
- Clinical trials have demonstrated the safety of pravastatin.
- Studies included diverse populations such as older adults and children with familial hypercholesterolemia.
Main Results:
- Pravastatin treatment is safe across different age groups and conditions.
- The medication consistently lowers LDL cholesterol levels.
- Risk reduction for cardiovascular death is approximately 24%.
Conclusions:
- Pravastatin is a safe and effective option for cardiovascular risk reduction.
- Its low cost makes generic pravastatin a potentially cost-effective intervention, especially in developing nations facing rising obesity rates.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Cholesterol: Significance and Regulation
Considering cholesterol and...
Coronary Artery Disease V: Interprofessional Care
Coronary Artery Disease IV: Preventive Measures
Cardiovascular Drugs: Classification based on Therapeutic Indications